Mcl-1 as a regulator of ovarian reserve.

Mcl-1 作为卵巢储备的调节剂。

• 批准号: 255916
• 负责人: Jurisicova Andrea
• 金额: $ 51.62万
• 依托单位: Sinai Health System (Toronto)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2012
• 资助国家: 加拿大
• 起止时间: 2012-03-01 至 2017-03-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=255916&lang=en
• 关键词: Cell Death; Maternal Aging; Oogenesis/Folliculogenesis; Premature Ovarian Failure

Finite number of female reproductive cells (eggs) at birth and their accelerated loss during fourth decade of life are two physiological factors regulating ovarian lifespan. As a result of premature exhaustion caused by excessive death, dwindling numbers

出生时有限数量的女性生殖细胞（卵子）和它们在生命的第四个十年期间加速损失是调节卵巢寿命的两个生理因素。由于过度死亡导致的过早衰竭，